CollPlant Biotechnologies Ltd. (CLGN)

CollPlant Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	56	73	93	175	71	22
Market Cap Growth	-21.98%	-20.95%	-47.08%	147.09%	225.56%	55.17%
Enterprise Value	35	50	66	135	71	22
PE Ratio	-	-10.43	-5.47	738.04	-12.26	-1.95
PS Ratio	5.24	6.68	309.61	11.18	11.54	9.38
PB Ratio	2.28	2.58	2.87	3.88	15.81	5.32
P/FCF Ratio	-18.08	-20.06	-6.17	185.10	-14.24	-3.04
P/OCF Ratio	-23.88	-26.49	-6.76	69.94	-15.90	-3.81
EV/Sales Ratio	3.34	4.53	220.17	8.65	11.54	9.31
EV/EBITDA Ratio	-5.96	-7.75	-4.11	161.37	-13.85	-3.04
EV/EBIT Ratio	-5.14	-6.61	-3.85	2080.37	-12.27	-2.83
EV/FCF Ratio	-12.12	-13.61	-4.38	143.09	-14.25	-3.01
Debt / Equity Ratio	0.12	0.11	0.09	0.08	0.76	0.89
Debt / EBITDA Ratio	-0.44	-0.49	-0.18	4.31	-0.66	-0.51
Debt / FCF Ratio	-0.89	-0.87	-0.19	3.82	-0.68	-0.51
Quick Ratio	6.89	8.33	9.73	14.60	1.30	1.20
Current Ratio	7.15	8.62	10.20	14.96	1.68	1.46
Asset Turnover	0.30	0.29	0.01	0.29	0.52	0.21
Interest Coverage	-	-	-	-	-	-2.16
Return on Equity (ROE)	-24.70%	-22.20%	-44.90%	0.50%	-94.70%	-584.00%
Return on Assets (ROA)	-20.90%	-18.80%	-39.50%	0.40%	-48.70%	-99.70%
Return on Capital (ROIC)	-30.30%	-23.85%	-48.58%	0.13%	-71.19%	-99.03%
Earnings Yield	-13.46%	-9.59%	-18.28%	0.14%	-8.16%	-51.34%
FCF Yield	-6.08%	-4.99%	-16.22%	0.54%	-7.02%	-32.95%
Buyback Yield / Dilution	-1.62%	-3.23%	7.80%	-73.76%	-38.12%	-13.73%
Total Shareholder Return	-1.62%	-3.23%	7.80%	-73.76%	-38.12%	-13.73%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).